This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: Jeremy Bryant Burton: Innovator in Retinopathy Treatment
Introduction
Jeremy Bryant Burton is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of medical science, particularly in the treatment of retinopathy. With a total of 3 patents to his name, Burton's work is paving the way for advancements in therapeutic methods.
Latest Patents
Burton's latest patents include innovative methods for treating retinopathy using anti-LRP5 antibodies. The first patent, titled "Method of treating retinopathy with an anti-LRP5 antibody," provides a detailed description of the anti-LRP5 antibodies and the methods for making and using them. The second patent, "Anti-LRP5 antibodies and methods of use," further elaborates on the applications of these antibodies in medical treatments.
Career Highlights
Jeremy Burton is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Yan Wu and Weilan Ye, who contribute to the collaborative environment that fosters innovation at Genentech.
Conclusion
Jeremy Bryant Burton is a distinguished inventor whose work in the field of retinopathy treatment is making a significant impact. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile